This article elaborates on the mechanism of action of a novel antibiotic compound against both, active and dormantMycobacterium tuberculosisand describes its pharmacokinetics (including oral bioavailability and toxicity). Information provided in this article serves useful during the search for drugs that shorten the treatment regimen for Tuberculosis and cause minimal adverse effects.